CVS Health Co. (NYSE:CVS) Stock Position Raised by Centaurus Financial Inc.

Centaurus Financial Inc. lifted its holdings in shares of CVS Health Co. (NYSE:CVS) by 2.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 15,390 shares of the pharmacy operator’s stock after buying an additional 301 shares during the period. Centaurus Financial Inc.’s holdings in CVS Health were worth $1,215,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of CVS. Checchi Capital Advisers LLC grew its position in shares of CVS Health by 2.3% during the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock valued at $726,000 after buying an additional 233 shares during the last quarter. Rafferty Asset Management LLC boosted its stake in CVS Health by 8.0% during the 3rd quarter. Rafferty Asset Management LLC now owns 134,018 shares of the pharmacy operator’s stock valued at $9,357,000 after purchasing an additional 9,961 shares during the period. QRG Capital Management Inc. acquired a new position in CVS Health during the 3rd quarter valued at about $8,961,000. Envestnet Portfolio Solutions Inc. acquired a new position in CVS Health during the 3rd quarter valued at about $7,871,000. Finally, Envestnet Asset Management Inc. boosted its stake in CVS Health by 15.5% during the 3rd quarter. Envestnet Asset Management Inc. now owns 2,592,508 shares of the pharmacy operator’s stock valued at $181,009,000 after purchasing an additional 347,939 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Down 1.3 %

Shares of CVS stock traded down $0.81 during trading hours on Friday, reaching $60.22. 11,690,758 shares of the stock traded hands, compared to its average volume of 12,659,378. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The business has a fifty day moving average price of $61.51 and a 200 day moving average price of $70.92. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. The firm has a market capitalization of $75.60 billion, a PE ratio of 10.58, a PEG ratio of 0.57 and a beta of 0.53.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). The company had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.20 EPS. On average, equities research analysts forecast that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were paid a $0.665 dividend. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.42%. CVS Health’s dividend payout ratio is presently 46.75%.

Wall Street Analyst Weigh In

CVS has been the subject of a number of analyst reports. TD Cowen lowered shares of CVS Health from a “buy” rating to a “hold” rating and reduced their target price for the company from $99.00 to $59.00 in a research note on Tuesday, May 7th. JPMorgan Chase & Co. reduced their target price on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Barclays reduced their price target on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, May 2nd. Argus reduced their price target on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, May 8th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $58.00 price target on shares of CVS Health in a research note on Wednesday. Eleven research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $75.05.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of the company’s stock in a transaction dated Thursday, May 2nd. The shares were bought at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the purchase, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.